Genome-wide characterization of miR-34a induced changes in protein and mRNA expression by a combined pulsed SILAC and microarray analysis

Molecular and Cellular Proteomics

Volumn 10, Issue 8, 2011, Pages

  Kaller, Markus ^a   Liffers, Sven Thorsten ^b   Oeljeklaus, Silke ^c   Kuhlmann, Katja ^b   Röh, Simone ^a   Hoffmann, Reinhard ^d   Warscheid, Bettina ^c   Hermeking, Heiko ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA; PROTEIN; PROTEIN P53; MIRN34 MICRORNA, HUMAN; PROTEOME; RENILLA LUCIFERIN 2 MONOOXYGENASE;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE; COLORECTAL CANCER; FLOW CYTOMETRY; GENETIC ANALYSIS; GENOME; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; TUMOR SUPPRESSOR GENE; BIOSYNTHESIS; DNA MICROARRAY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN GENOME; ISOTOPE LABELING; METABOLISM; PHYSIOLOGY; REPORTER GENE; TUMOR CELL LINE;

CELL LINE, TUMOR; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENES, REPORTER; GENES, TUMOR SUPPRESSOR; GENOME, HUMAN; HUMANS; ISOTOPE LABELING; LUCIFERASES, RENILLA; METABOLIC NETWORKS AND PATHWAYS; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEOME; RNA, MESSENGER;

EID: 80051613002     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M111.010462     Document Type: Article

References (70)

1. Vogelstein, B., Lane, D., and Levine, A. J. (2000) Surfing the p53 network. Nature 408, 307-310
2. Hermeking, H. (2007) p53 enters the microRNA world. Cancer Cell 12, 414-418
3. He, X., He, L., and Hannon, G. J. (2007) The guardian's little helper: microRNAs in the p53 tumor suppressor network. Cancer Res. 67, 11099-11101 (Pubitemid 350248530)
4. Friedman, R. C., Farh, K. K., Burge, C. B., and Bartel, D. P. (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19, 92-105
5. Bommer, G. T., Gerin, I., Feng, Y., Kaczorowski, A. J., Kuick, R., Love, R. E., Zhai, Y., Giordano, T. J., Qin, Z. S., Moore, B. B., MacDougald, O. A., Cho, K. R., and Fearon, E. R. (2007) p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr. Biol. 17, 1298-1307 (Pubitemid 47176893)
6. Chang, T. C., Wentzel, E. A., Kent, O. A., Ramachandran, K., Mullendore, M., Lee, K. H., Feldmann, G., Yamakuchi, M., Ferlito, M., Lowenstein, C. J., Arking, D. E., Beer, M. A., Maitra, A., and Mendell, J. T. (2007) Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol. Cell. 26, 745-752 (Pubitemid 46856245)
7. He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., Jackson, A. L., Linsley, P. S., Chen, C., Lowe, S. W., Cleary, M. A., and Hannon, G. J. (2007) A microRNA component of the p53 tumour suppressor network. Nature 447, 1130-1134 (Pubitemid 47014436)
8. Raver-Shapira, N., Marciano, E., Meiri, E., Spector, Y., Rosenfeld, N., Moskovits, N., Bentwich, Z., and Oren, M. (2007) Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol. Cell. 26, 731-743 (Pubitemid 46856247)
9. Tarasov, V., Jung, P., Verdoodt, B., Lodygin, D., Epanchintsev, A., Menssen, A., Meister, G., and Hermeking, H. (2007) Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 6, 1586-1593 (Pubitemid 47327945)
10. Lodygin, D., Tarasov, V., Epanchintsev, A., Berking, C., Knyazeva, T., Körner, H., Knyazev, P., Diebold, J., and Hermeking, H. (2008) Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 7, 2591-2600
11. Hermeking, H. (2010) The miR-34 family in cancer and apoptosis. Cell Death Differ. 17, 193-199
12. Vogt, M., Munding, J., Grüner, M., Liffers, S. T., Verdoodt, B., Hauk, J., Steinstraesser, L., Tannapfel, A., and Hermeking, H. (2011) Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas. Virchows Arch. 458, 313-322
13. Fabian, M. R., Sonenberg, N., and Filipowicz, W. (2010) Regulation of mRNA translation and stability by microRNAs. Annu. Rev. Biochem. 79, 351-379
14. Huntzinger, E., and Izaurralde, E. (2011) Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat. Rev. Genet. 12, 99-110
15. Bartel, D. P. (2009) MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233
16. Thomas, M., Lieberman, J., and Lal, A. (2010) Desperately seeking microRNA targets. Nat. Struct. Mol. Biol. 17, 1169-1174
17. Ong, S. E., Blagoev, B., Kratchmarova, I., Kristensen, D. B., Steen, H., Pandey, A., and Mann, M. (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell Proteomics 1, 376-386
18. Selbach, M., Schwanhäusser, B., Thierfelder, N., Fang, Z., Khanin, R., and Rajewsky, N. (2008) Widespread changes in protein synthesis induced by microRNAs. Nature 455, 58-63
19. Epanchintsev, A., Jung, P., Menssen, A., and Hermeking, H. (2006) Inducible microRNA expression by an all-in-one episomal vector system. Nucleic Acids Res. 34, e119
20. Bornkamm, G. W., Berens, C., Kuklik-Roos, C., Bechet, J. M., Laux, G., Bachl, J., Korndoerfer, M., Schlee, M., Hölzel, M., Malamoussi, A., Chapman, R. D., Nimmerjahn, F., Mautner, J., Hillen, W., Bujard, H., and Feuillard, J. (2005) Stringent doxycycline-dependent control of gene activities using an episomal one-vector system. Nucleic Acids Res. 33, e137
21. Molloy, D. P., Barral, P. M., Bremner, K. H., Gallimore, P. H., and Grand, R. J. (2001) Structural determinants outside the PXDLS sequence affect the interaction of adenovirus E1A, C-terminal interacting protein and Drosophila repressors with C-terminal binding protein. Biochim. Biophys. Acta. 1546, 55-70 (Pubitemid 32217802)
22. Krueger, C., Danke, C., Pfleiderer, K., Schuh, W., Jäck, H. M., Lochner, S., Gmeiner, P., Hillen, W., and Berens, C. (2006) A gene regulation system with four distinct expression levels. J. Gene Med. 8, 1037-1047 (Pubitemid 44283000)
23. Wiese, S., Gronemeyer, T., Ofman, R., Kunze, M., Grou, C. P., Almeida, J. A., Eisenacher, M., Stephan, C., Hayen, H., Schollenberger, L., Korosec, T., Waterham, H. R., Schliebs, W., Erdmann, R., Berger, J., Meyer, H. E., Just, W., Azevedo, J. E., Wanders, R. J., and Warscheid, B. (2007) Proteomics characterization of mouse kidney peroxisomes by tandem mass spectrometry and protein correlation profiling. Mol. Cell Proteomics 6, 2045-2057
24. Cox, J., and Mann, M. (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367-1372
25. Wood, L. D., Parsons, D. W., Jones, S., Lin, J., Sjöblom, T., Leary, R. J., Shen, D., Boca, S. M., Barber, T., Ptak, J., Silliman, N., Szabo, S., Dezso, Z., Ustyanksky, V., Nikolskaya, T., Nikolsky, Y., Karchin, R., Wilson, P. A., Kaminker, J. S., Zhang, Z., Croshaw, R., Willis, J., Dawson, D., Shipitsin, M., Willson, J. K., Sukumar, S., Polyak, K., Park, B. H., Pethiyagoda, C. L., Pant, P. V., Ballinger, D. G., Sparks, A. B., Hartigan, J., Smith, D. R., Suh, E., Papadopoulos, N., Buckhaults, P., Markowitz, S. D., Parmigiani, G., Kinzler, K. W., Velculescu, V. E., and Vogelstein, B. (2007) The genomic landscapes of human breast and colorectal cancers. Science 318, 1108-1113 (Pubitemid 350134889)
26. Pan, C., Olsen, J. V., Daub, H., and Mann, M. (2009) Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics. Mol. Cell Proteomics 8, 2796-2808
27. Perkins, D. N., Pappin, D. J., Creasy, D. M., and Cottrell, J. S. (1999) Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20, 3551-3567 (Pubitemid 30007252)
28. Motulsky, H. (1995) Intuitive Biostatistics. Oxford University Press, New York
29. Tukey, J. W. (1990) Data-based graphics: visual display in the decades to come. Stat. Sci. 5, 327-339
30. Krek, A., Grün, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., MacMenamin, P., da, Piedade, I., Gunsalus, K. C., Stoffel, M., and Rajewsky, N. (2005) Combinatorial microRNA target predictions. Nat. Genet. 37, 495-500 (Pubitemid 40617277)
31. Grimson, A., Farh, K. K., Johnston, W. K., Garrett-Engele, P., Lim, L. P., and Bartel, D. P. (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell. 27, 91-105 (Pubitemid 46991392)
32. Welch, C., Chen, Y., and Stallings, R. L. (2007) MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 26, 5017-5022 (Pubitemid 47172643)
33. Schwanhäusser, B., Gossen, M., Dittmar, G., and Selbach, M. (2009) Global analysis of cellular protein translation by pulsed SILAC. Proteomics. 9, 205-209
34. Lujambio, A., Calin, G. A., Villanueva, A., Ropero, S., Sánchez-Céspedes, M., Blanco, D., Montuenga, L. M., Rossi, S., Nicoloso, M. S., Faller, W. J., Gallagher, W. M., Eccles, S. A., Croce, C. M., and Esteller, M. (2008) A microRNA DNA methylation signature for human cancer metastasis. Proc. Natl. Acad. Sci. U.S.A. 105, 13556-13561
35. Ma, L., Young, J., Prabhala, H., Pan, E., Mestdagh, P., Muth, D., Teruya-Feldstein, J., Reinhardt, F., Onder, T. T., Valastyan, S., Westermann, F., Speleman, F., Vandesompele, J., and Weinberg, R. A. (2010) miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat. Cell Biol. 12, 247-256
36. Johnson, S. M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., Labourier, E., Reinert, K. L., Brown, D., and Slack, F. J. (2005) RAS is regulated by the let-7 microRNA family. Cell 120, 635-647 (Pubitemid 40343076)
37. Djuranovic, S., Nahvi, A., and Green, R. (2011) A parsimonious model for gene regulation by miRNAs. Science 331, 550-553
38. John, B., Enright, A. J., Aravin, A., Tuschl, T., Sander, C., and Marks, D. S. (2004) Human MicroRNA targets. PLoS Biol. 2, e363
39. Davis, M. E., Zuckerman, J. E., Choi, C. H., Seligson, D., Tolcher, A., Alabi, C. A., Yen, Y., Heidel, J. D., and Ribas, A. (2010) Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 464, 1067-1070
40. Warburg, O. (1956) On the origin of cancer cells. Science 123, 309-314
41. Levine, A. J., and Puzio-Kuter, A. M. (2010) The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 330, 1340-1344
42. Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N., Nakano, K., Bartrons, R., Gottlieb, E., and Vousden, K. H. (2006) TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126, 107-120 (Pubitemid 44040989)
43. Matoba, S., Kang, J. G., Patino, W. D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P. J., Bunz, F., and Hwang, P. M. (2006) p53 regulates mitochondrial respiration. Science 312, 1650-1653 (Pubitemid 43902663)
44. Fantin, V. R., St-Pierre, J., and Leder, P. (2006) Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 9, 425-434 (Pubitemid 43832190)
45. Dang, C. V., Kim, J. W., Gao, P., and Yustein, J. (2008) The interplay between MYC and HIF in cancer. Nat. Rev. Cancer 8, 51-56
46. Hashimi, S. T., Fulcher, J. A., Chang, M. H., Gov, L., Wang, S., and Lee, B. (2009) MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the coordinate regulation of dendritic cell differentiation. Blood 114, 404-414
47. Toyota, M., Suzuki, H., Sasaki, Y., Maruyama, R., Imai, K., Shinomura, Y., and Tokino, T. (2008) Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res. 68, 4123-4132
48. Yamakuchi, M., Ferlito, M., and Lowenstein, C. J. (2008) miR-34a repression of SIRT1 regulates apoptosis. Proc. Natl. Acad. Sci. U.S.A. 105, 13421-13426
49. Luo, J., Su, F., Chen, D., Shiloh, A., and Gu, W. (2000) Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature 408, 377-381
50. Grönroos, E., Terentiev, A. A., Punga, T., and Ericsson, J. (2004) YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress. Proc. Natl. Acad. Sci. U.S.A. 101, 12165-12170 (Pubitemid 39145414)
51. Sui, G., Affar el, B., Shi, Y., Brignone, C., Wall, N. R., Yin, P., Donohoe, M., Luke, M. P., Calvo, D., Grossman, S. R., and Shi, Y. (2004) Yin Yang 1 is a negative regulator of p53. Cell 117, 859-872
52. Chen, Q. R., Yu, L. R., Tsang, P., Wei, J. S., Song, Y. K., Cheuk, A., Chung, J. Y., Hewitt, S. M., Veenstra, T. D., and Khan, J. (2011) Systematic Proteome Analysis Identifies Transcription Factor YY1 as a Direct Target of miR-34a. J. Proteome Res. 10, 479-487
53. Senese, S., Zaragoza, K., Minardi, S., Muradore, I., Ronzoni, S., Passafaro, A., Bernard, L., Draetta, G. F., Alcalay, M., Seiser, C., and Chiocca, S. (2007) Role for histone deacetylase 1 in human tumor cell proliferation. Mol. Cell. Biol. 27, 4784-4795 (Pubitemid 47016131)
54. Yamaguchi, T., Cubizolles, F., Zhang, Y., Reichert, N., Kohler, H., Seiser, C., and Matthias, P. (2010) Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression. Genes Dev. 24, 455-469
55. Lagger, G., Doetzlhofer, A., Schuettengruber, B., Haidweger, E., Simboeck, E., Tischler, J., Chiocca, S., Suske, G., Rotheneder, H., Wintersberger, E., and Seiser, C. (2003) The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene. Mol. Cell. Biol. 23, 2669-2679 (Pubitemid 36403069)
56. Zupkovitz, G., Grausenburger, R., Brunmeir, R., Senese, S., Tischler, J., Jurkin, J., Rembold, M., Meunier, D., Egger, G., Lagger, S., Chiocca, S., Propst, F., Weitzer, G., and Seiser, C. (2010) The cyclin-dependent kinase inhibitor p21 is a crucial target for histone deacetylase 1 as a regulator of cellular proliferation. Mol. Cell. Biol. 30, 1171-1181
57. Janssen, J. W., Schulz, A. S., Steenvoorden, A. C., Schmidberger, M., Strehl, S., Ambros, P. F., and Bartram, C. R. (1991) A novel putative tyrosine kinase receptor with oncogenic potential. Oncogene 6, 2113-2120 (Pubitemid 21924053)
58. O'Bryan, J. P., Frye, R. A., Cogswell, P. C., Neubauer, A., Kitch, B., Prokop, C., Espinosa, R., 3rd, Le Beau, M. M., Earp, H. S., and Liu, E. T. (1991) axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase. Mol. Cell. Biol. 11, 5016-5031 (Pubitemid 21895263)
59. Holland, S. J., Powell, M. J., Franci, C., Chan, E. W., Friera, A. M., Atchison, R. E., McLaughlin, J., Swift, S. E., Pali, E. S., Yam, G., Wong, S., Lasaga, J., Shen, M. R., Yu, S., Xu, W., Hitoshi, Y., Bogenberger, J., Nör, J. E., Payan, D. G., and Lorens, J. B. (2005) Multiple roles for the receptor tyrosine kinase axl in tumor formation. Cancer Res. 65, 9294-9303 (Pubitemid 41507996)
60. Vajkoczy, P., Knyazev, P., Kunkel, A., Capelle, H. H., Behrndt, S., von Tengg-Kobligk, H., Kiessling, F., Eichelsbacher, U., Essig, M., Read, T. A., Erber, R., and Ullrich, A. (2006) Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival. Proc. Natl. Acad. Sci. U.S.A. 103, 5799-5804
61. Zhang, Y. X., Knyazev, P. G., Cheburkin, Y. V., Sharma, K., Knyazev, Y. P., Orfi, L., Szabadkai, I., Daub, H., Kéri, G., and Ullrich, A. (2008) AXL is a potential target for therapeutic intervention in breast cancer progression. Cancer Res. 68, 1905-1915 (Pubitemid 351416577)
62. Corney, D. C., Hwang, C. I., Matoso, A., Vogt, M., Flesken-Nikitin, A., Godwin, A. K., Kamat, A. A., Sood, A. K., Ellenson, L. H., Hermeking, H., and Nikitin, A. Y. (2010) Frequent downregulation of miR-34 family in human ovarian cancers. Clin. Cancer Res. 16, 1119-1128
63. Guha, M., and Altieri, D. C. (2009) Survivin as a global target of intrinsic tumor suppression networks. Cell Cycle 8, 2708-2710
64. Merlos-Suárez, A., and Batlle, E. (2008) Eph-ephrin signalling in adult tissues and cancer. Curr. Opin. Cell Biol. 20, 194-200
65. Bouhallier, F., Allioli, N., Lavial, F., Chalmel, F., Perrard, M. H., Durand, P., Samarut, J., Pain, B., and Rouault, J. P. (2010) Role of miR-34c microRNA in the late steps of spermatogenesis. Rna. 16, 720-731
66. Mudduluru, G., Ceppi, P., Kumarswamy, R., Scagliotti, G. V., Papotti, M., and Allgayer, H. (2011) Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer. Oncogene 30, 2888-2889
67. Li, W. Q., Chen, C., Xu, M. D., Guo, J., Li, Y. M., Xia, Q. M., Liu, H. M., He, J., Yu, H. Y., and Zhu, L. (2011) The rno-miR-34 family is upregulated and targets ACSL1 in dimethylnitrosamine-induced hepatic fibrosis in rats. Febs J. 278, 1522-1532
68. Liu, C., Kelnar, K., Liu, B., Chen, X., Calhoun-Davis, T., Li, H., Patrawala, L., Yan, H., Jeter, C., Honorio, S., Wiggins, J. F., Bader, A. G., Fagin, R., Brown, D., and Tang, D. G. (2011) The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med. 17, 211-215
69. Trang, P., Wiggins, J. F., Daige, C. L., Cho, C., Omotola, M., Brown, D., Weidhaas, J. B., Bader, A. G., and Slack, F. J. (2011) Systemic delivery of tumor suppressor microrna mimics using a neutral lipid emulsion inhibits lung tumors in mice. Mol. Ther. 19, 1116-1112
70. Wiggins, J. F., Ruffino, L., Kelnar, K., Omotola, M., Patrawala, L., Brown, D., and Bader, A. G. (2010) Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res. 70, 5923-5930